Mr. William F. Doyle is an Independent Director at Elanco Animal Health, Inc., a Lead Independent Director at Minerva Neurosciences, Inc., an Executive Chairman at NovoCure Ltd., a Co-Founder & Managing Director at WFD Ventures LLC and an Executive Chairman at Blink Health, Inc. He is on the Board of Directors at Elanco Animal Health, Inc., Minerva Neurosciences, Inc., OptiNose US, Inc., Aspire Bariatrics, Inc. and VisionScope Technologies LLC. Mr. Doyle was previously employed as an Independent Director by Zoetis, Inc., a Member-Investment Team by Pershing Square Capital Management LP, an Independent Director by OptiNose, Inc., a Non-Executive Director by Advanced Surgical Concepts Ltd., a Principal by American Superconductor Corp., a President by Biosense Webster, Inc., an Advisor by Cutlass Capital LLC, a Founder by Durel Corp, a Chairman by ImaCor, Inc., a Managing Director by Insight Venture Management LLC, a Vice President-Licensing & Acquisitions by Johnson & Johnson, and a Consultant by McKinsey & Co., Inc. He also served on the board at OptiNose AS, Revitas, Inc., Andrew Technologies LLC, Angioslide Ltd., BionX Medical Technologies, Inc., Clozex Medical LLC, Cordis Corp., Inventure LLC, Johnson & Johnson Innovation JJDC, Inc., Medusind of Miami, Inc., NanoPass Technologies Ltd., ProterixBio, Inc. and Vision-Sciences, Inc. He received his undergraduate degree from Massachusetts Institute of Technology and an MBA from Harvard Business School.